Pancreatic Cancer Research

ResearcherKansai Medical UniversityActive in the last 2 years

Takashi Ito

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-4148-4086; OpenAlex author ID A5082340729. Sources: OpenAlex.

Their work

Papers
10 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
39
Papers, trials and grants by year

2019: 1 paper · 2020: 1 paper · 2021: 1 paper · 2022: none · 2023: 3 papers · 2024: 1 paper · 2025: none · 2026: 3 papers

Papers 10

  1. Fecal Bifidobacterium Serves as a Predictor of Postoperative Recurrence After Neoadjuvant Chemotherapy in Pancreatic Cancer. Co-author DOI 10.1016/j.gastha.2025.100779↗
  2. Multi-hole Versus Fully Covered Self-expandable Metal Stents for Distal Biliary Obstruction in Unresectable Pancreatic Cancer. Co-author DOI 10.1097/mpa.0000000000002722↗
  3. Impact of Stent Type on Surgical Outcomes in Pancreatic Cancer Patients Undergoing Preoperative Biliary Drainage. Co-author DOI 10.1111/den.70229↗
  4. Impact of endoscopic ultrasound-guided tissue acquisition on prognosis and peritoneal lavage cytology in resectable or borderline resectable pancreatic ductal … Co-author DOI 10.1016/j.pan.2024.06.001↗
  5. Impact of neoadjuvant therapy on gut microbiome in patients with resectable/borderline resectable pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.pan.2023.04.001↗
  6. Preoperative Endoscopic Minor Papilla Sphincterotomy for Pancreas Divisum in a Patient with Pancreatic Cancer Who Underwent Laparoscopic Distal Pancreatectomy. Co-author DOI 10.1245/s10434-023-13975-6↗
  7. A Retrospective Study Investigating the Safety and Efficacy of Nanoliposomal Irinotecan in Elderly Patients with Unresectable Pancreatic Cancer. Co-author DOI 10.3390/jcm12103477↗
  8. A Case of Misdiagnosed Pancreatic Cancer With Concomitant Type 1 Autoimmune Pancreatitis. First author DOI 10.1097/mpa.0000000000001727↗
  9. Usefulness of half-covered metallic stent placement in preventing acute cholecystitis complication in pancreatic cancer-induced distal biliary stricture. Co-author DOI 10.1002/jgh3.12409↗
  10. Diffuse Pancreatic Cancer Mimicking Autoimmune Pancreatitis. Co-author DOI 10.2169/internalmedicine.2689-19↗

Closest collaborators

The 25 strongest of 39 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Tsukasa Ikeura · 8 shared papers, 2019–2026 · strength 1.37
  2. Makoto Naganuma · 6 shared papers, 2020–2026 · strength 1.08
  3. Koh Nakamaru · 6 shared papers, 2020–2026 · strength 1.08
  4. Sohei Satoi · 5 shared papers, 2023–2026 · strength 0.97
  5. Daisuke Hashimoto · 5 shared papers, 2023–2026 · strength 0.97
  6. So Yamaki · 4 shared papers, 2023–2026 · strength 0.69
  7. Ayaka Takaori · 3 shared papers, 2023–2026 · strength 0.54
  8. Masashi Kanai · 2 shared papers, 2026 · strength 0.52
  9. Motonobu Maruo · 2 shared papers, 2024–2026 · strength 0.40
  10. Hidetaka Miyazaki · 2 shared papers, 2024–2026 · strength 0.40
  11. Makoto Takaoka · 3 shared papers, 2019–2024 · strength 0.36
  12. Toshihiko Masui · 2 shared papers, 2021–2023 · strength 0.32
  13. Tomohisa Yamamoto · 2 shared papers, 2023 · strength 0.29
  14. Akiko Tsujimoto · 1 shared paper, 2026 · strength 0.20
  15. Koh Kitagawa · 1 shared paper, 2026 · strength 0.20
  16. Yuki Ishikawa‐Kakiya · 1 shared paper, 2026 · strength 0.20
  17. Mamoru Takenaka · 1 shared paper, 2026 · strength 0.20
  18. Tomoya Emori · 1 shared paper, 2026 · strength 0.20
  19. Yoshihiro Nishikawa · 1 shared paper, 2026 · strength 0.20
  20. Tomoaki Matsumori · 1 shared paper, 2026 · strength 0.20
  21. Atsuhiro Masuda · 1 shared paper, 2026 · strength 0.20
  22. Toshifumi Doi · 1 shared paper, 2026 · strength 0.20
  23. Takuo Yamai · 1 shared paper, 2026 · strength 0.20
  24. Takashi Tamura · 1 shared paper, 2026 · strength 0.20
  25. Minako Nagai · 1 shared paper, 2026 · strength 0.20

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.